Tudor Investment Corp’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-22,989	Closed	-$2.47M	–	2111
2023 Q1	$2.47M	Buy	22,989 +2,386	+12%	+$256K	0.04%	567
2022 Q4	$2.27M	Buy	20,603 +413	+2%	+$45.4K	0.04%	486
2022 Q3	$1.19M	Buy	+20,190	New	+$1.19M	0.03%	739